{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:02:50Z","timestamp":1790845370204,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-D-002"],"award-info":[{"award-number":["2022-PUMCH-D-002"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-013"],"award-info":[{"award-number":["2022-PUMCH-B-013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>Undifferentiated or undefined systemic autoinflammatory disease (uSAID) encompasses a group of rare, heterogeneous diseases characterized by the features of well-defined systemic autoinflammatory diseases (SAIDs), but lacking diagnostic phenotypes or genetic confirmation. We aimed to describe the phenotypes, genotypes and treatment responses of Chinese adult patients with uSAID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The final diagnosis of uSAID was reached in 61 patients, whose organ-specific inflammation was compared and three subgroups were identified based on phenotypic similarities to well-defined SAIDs. Phenotypes, genotypes and treatment responses were analyzed in these subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 61 uSAID patients, 17 had disease-onset during childhood, and 44 had adult-onset. Compared to those without pulmonary manifestations, patients with pulmonary involvement exhibited higher frequencies of myalgia, skin lesions, cardiac involvement, gastrointestinal involvement, urinary involvement, lymphadenopathy, headache, and intellectual impairments. Twenty-four patients exhibited monogenic SAID-like phenotypes, 12 had polygenic SAID-like phenotypes, and the remaining 25 were categorized as having atypical phenotypes. Among the 53 patients followed, 25% (13\/53) improved spontaneously with complete or partial recovery independent of therapy. Patients with atypical phenotypes had the highest spontaneous remission rate (10\/23, 43%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study is the first to describe the clinical and genetic features of a cohort of Chinese adult patients with uSAID. Patients with pulmonary manifestations may be more prone to developing complex phenotypes, while those with atypical phenotypes have a high rate of spontaneous remission, indicating a favorable prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03685-5","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T03:19:10Z","timestamp":1744082350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Undifferentiated autoinflammatory disease in adults: a prospective study in 61 patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Junke","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1912-126X","authenticated-orcid":false,"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"3685_CR1","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2017-212515","volume":"77","author":"E Ben-Chetrit","year":"2018","unstructured":"Ben-Chetrit E, Gattorno M, Gul A, Kastner DL, Lachmann HJ, Touitou I, et al. Paediatric rheumatology international trials organisation (PRINTO) and the aids Delphi study participants. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study. Ann Rheum Dis. 2018;77:1558\u201365.","journal-title":"Ann Rheum Dis"},{"key":"3685_CR2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010;140:784\u201390.","journal-title":"Cell"},{"key":"3685_CR3","doi-asserted-by":"crossref","first-page":"102421","DOI":"10.1016\/j.jaut.2020.102421","volume":"109","author":"J Krainer","year":"2020","unstructured":"Krainer J, Siebenhandl S, Weinh\u00e4usel A. Systemic autoinflammatory diseases. J Autoimmun. 2020;109:102421.","journal-title":"J Autoimmun"},{"key":"3685_CR4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/keaa165","volume":"60","author":"C Kosukcu","year":"2021","unstructured":"Kosukcu C, Taskiran EZ, Batu ED, Sag E, Bilginer Y, Alikasifoglu M, et al. Whole exome sequencing in unclassified autoinflammatory diseases: more Monogenic diseases in the pipeline? Rheumatology (Oxford). 2021;60:607\u201316.","journal-title":"Rheumatology (Oxford)"},{"key":"3685_CR5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cge.13789","volume":"98","author":"EN Suspitsin","year":"2020","unstructured":"Suspitsin EN, Guseva MN, Kostik MM, Sokolenko AP, Skripchenko NV, Levina AS, et al. Next generation sequencing analysis of consecutive Russian patients with clinical suspicion of inborn errors of immunity. Clin Genet. 2020;98:231\u20139.","journal-title":"Clin Genet"},{"key":"3685_CR6","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1136\/annrheumdis-2018-214472","volume":"78","author":"NM Ter Haar","year":"2019","unstructured":"Ter Haar NM, Eijkelboom C, Cantarini L, Papa R, Brogan PA, Kone-Paut I, et al. Eurofever registry and the pediatric rheumatology international trial organization (PRINTO). Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases. Ann Rheum Dis. 2019;78:1405\u201311.","journal-title":"Ann Rheum Dis"},{"key":"3685_CR7","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.1780401023","volume":"40","author":"A Livneh","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of Familial mediterranean fever. Arthritis Rheum. 1997;40:1879\u201385.","journal-title":"Arthritis Rheum"},{"key":"3685_CR8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD)","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD). The international criteria for Beh\u00e7et\u2019s disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338\u201347.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3685_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomoll\u00f3n","year":"2017","unstructured":"Gomoll\u00f3n F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. 3rd European Evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11:3\u201325.","journal-title":"J Crohns Colitis"},{"key":"3685_CR10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/mpd.2002.126457","volume":"141","author":"AM Huber","year":"2002","unstructured":"Huber AM, Lam PY, Duffy CM, Yeung RS, Ditchfield M, Laxer D, et al. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr. 2002;141:198\u2013203.","journal-title":"J Pediatr"},{"key":"3685_CR11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2014.01.008","volume":"13","author":"SK Raychaudhuri","year":"2014","unstructured":"Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014;13:490\u20135.","journal-title":"Autoimmun Rev"},{"key":"3685_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-3476(99)70321-5","volume":"135","author":"KT Thomas","year":"1999","unstructured":"Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr. 1999;135:15\u201321.","journal-title":"J Pediatr"},{"key":"3685_CR13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","volume":"78","author":"M Gattorno","year":"2019","unstructured":"Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019;78:1025\u201332.","journal-title":"Ann Rheum Dis"},{"key":"3685_CR14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"3685_CR15","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s10067-016-3410-y","volume":"36","author":"M Shen","year":"2017","unstructured":"Shen M, Tang L, Shi X, Zeng X, Yao Q. NLRP12 autoinflammatory disease: a Chinese case series and literature review. Clin Rheumatol. 2017;36:1661\u20137.","journal-title":"Clin Rheumatol"},{"key":"3685_CR16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2017-212403","volume":"77","author":"FA Aeschlimann","year":"2018","unstructured":"Aeschlimann FA, Batu ED, Canna SW, Go E, G\u00fcl A, Hoffmann P, et al. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018;77:728\u201335.","journal-title":"Ann Rheum Dis"},{"key":"3685_CR17","doi-asserted-by":"crossref","first-page":"152195","DOI":"10.1016\/j.semarthrit.2023.152195","volume":"60","author":"D Sutera","year":"2023","unstructured":"Sutera D, Bustaffa M, Papa R, Matucci-Cerinic C, Matarese S, D\u2019Orsi C, et al. Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF). Semin Arthritis Rheum. 2023;60:152195.","journal-title":"Semin Arthritis Rheum"},{"key":"3685_CR18","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/jcm10091963","volume":"10","author":"R Papa","year":"2021","unstructured":"Papa R, Penco F, Volpi S, Sutera D, Caorsi R, Gattorno M. Syndrome of undifferentiated recurrent fever (SURF): an emerging group of autoinflammatory recurrent fevers. J Clin Med. 2021;10:1963.","journal-title":"J Clin Med"},{"key":"3685_CR19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/rheumatology\/kez270","volume":"59","author":"R Papa","year":"2020","unstructured":"Papa R, Rusmini M, Volpi S, Caorsi R, Picco P, Grossi A, et al. Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers. Rheumatology (Oxford). 2020;59:344\u201360.","journal-title":"Rheumatology (Oxford)"},{"key":"3685_CR20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/14397595.2020.1784542","volume":"31","author":"Y Hidaka","year":"2021","unstructured":"Hidaka Y, Fujimoto K, Matsuo N, Koga T, Kaieda S, Yamasaki S, et al. Clinical phenotypes and genetic analyses for diagnosis of systemic autoinflammatory diseases in adult patients with unexplained fever. Mod Rheumatol. 2021;31:704\u20139.","journal-title":"Mod Rheumatol"},{"key":"3685_CR21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","volume":"11","author":"CA Wise","year":"2002","unstructured":"Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet. 2002;11:961\u20139.","journal-title":"Hum Mol Genet"},{"key":"3685_CR22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911\u201320.","journal-title":"N Engl J Med"},{"key":"3685_CR23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.semarthrit.2019.05.002","volume":"49","author":"Y Hua","year":"2019","unstructured":"Hua Y, Wu D, Shen M, Yu K, Zhang W, Zeng X. Phenotypes and genotypes of Chinese adult patients with systemic autoinflammatory diseases. Semin Arthritis Rheum. 2019;49:446\u201352.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"3685_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.autrev.2015.08.008","volume":"15","author":"J Hern\u00e1ndez-Rodr\u00edguez","year":"2016","unstructured":"Hern\u00e1ndez-Rodr\u00edguez J, Ru\u00edz-Ortiz E, Tom\u00e9 A, et al. Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center. Autoimmun Rev. 2016;15(1):9\u201315.","journal-title":"Autoimmun Rev"},{"key":"3685_CR25","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3390\/ijms17122111","volume":"17","author":"G Tarantino","year":"2016","unstructured":"Tarantino G, Esposito S, Andreozzi L, Bracci B, D\u2019Errico F, Rigante D. Lung involvement in children with hereditary autoinflammatory disorders. Int J Mol Sci. 2016;17:2111.","journal-title":"Int J Mol Sci"},{"key":"3685_CR26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/rheumatology\/ket211","volume":"53","author":"SM Keidel","year":"2014","unstructured":"Keidel SM, Hoyles RK, Wilkinson NM. Efficacy of Tocilizumab for interstitial lung disease in an undifferentiated autoinflammatory disorder partially responsive to Anakinra. Rheumatology (Oxford). 2014;53:573\u20134.","journal-title":"Rheumatology (Oxford)"},{"key":"3685_CR27","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI129301","volume":"130","author":"AA de Jesus","year":"2020","unstructured":"de Jesus AA, Hou Y, Brooks S, Malle L, Biancotto A, Huang Y, et al. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. J Clin Invest. 2020;130:1669\u201382.","journal-title":"J Clin Invest"},{"key":"3685_CR28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fimmu.2013.00351","volume":"4","author":"S Federici","year":"2013","unstructured":"Federici S, Martini A, Gattorno M. The central role of Anti-IL-1 Blockade in the treatment of Monogenic and Multi-Factorial autoinflammatory diseases. Front Immunol. 2013;4:351.","journal-title":"Front Immunol"},{"key":"3685_CR29","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","volume":"360","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, et al. Canakinumab in CAPS study group. Use of Canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360:2416\u201325.","journal-title":"N Engl J Med"},{"key":"3685_CR30","doi-asserted-by":"crossref","first-page":"rkz004","DOI":"10.1093\/rap\/rkz004","volume":"3","author":"S Garg","year":"2019","unstructured":"Garg S, Wynne K, Omoyinmi E, Eleftheriou D, Brogan P. Efficacy and safety of Anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review. Rheumatol Adv Pract. 2019;3:rkz004.","journal-title":"Rheumatol Adv Pract"},{"key":"3685_CR31","doi-asserted-by":"crossref","first-page":"e86336","DOI":"10.1172\/jci.insight.86336","volume":"1","author":"SR Harrison","year":"2016","unstructured":"Harrison SR, McGonagle D, Nizam S, Jarrett S, van der Hilst J, McDermott MF, et al. Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology. JCI Insight. 2016;1:e86336.","journal-title":"JCI Insight"},{"key":"3685_CR32","doi-asserted-by":"crossref","first-page":"e001246","DOI":"10.1136\/rmdopen-2020-001246","volume":"6","author":"M Kacar","year":"2020","unstructured":"Kacar M, Fitton J, Gough AK, Buch MH, McGonagle DG, Savic S. Mixed results with baricitinib in biological-resistant adult-onset still\u2019s disease and undifferentiated systemic autoinflammatory disease. RMD Open. 2020;6:e001246.","journal-title":"RMD Open"},{"key":"3685_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13075-019-2017-5","volume":"21","author":"J Chen","year":"2019","unstructured":"Chen J, Luo Y, Zhao M, Wu D, Yang Y, Zhang W, Shen M, et al. Effective treatment of TNF\u03b1 inhibitors in Chinese patients with Blau syndrome. Arthritis Res Ther. 2019;21:236.","journal-title":"Arthritis Res Ther"},{"key":"3685_CR34","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/joim.13334","volume":"290","author":"N Wu","year":"2021","unstructured":"Wu N, Wu D, Zhao M, Miao J, Yu W, Wang Y, et al. Clinical benefits of TNF-\u03b1 inhibitors in Chinese adult patients with NLRP3-associated autoinflammatory disease. J Intern Med. 2021;290:878\u201385.","journal-title":"J Intern Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03685-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:09:53Z","timestamp":1744204193000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03685-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3685"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03685-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"17 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical no: ZS-3272. Approved by the Institutional Review Board of Peking Union Medical College Hospital (PUMCH). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"165"}}